Published

Two Novel Epilepsy Treatments Headed for Pivotal Trials

Summary by mdedge.com
Two new drugs are headed toward pivotal trials after making their endpoints in phase 2 treatment-resistant epilepsy studies.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.